Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sedana Medical ABOSTO:SEDANA -1.01%69 Days Payable is 49.25 as of Jun. 2026, which is 52% below its 10-year median of 101.90. GuruFocus rates OSTO:SEDANA with a GF Score™ of 69/100 and a GF Value™ of kr17.42 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Sedana Medical AB ranks worse than 75.85% on this metric.
The historical rank and industry rank for Sedana Medical AB's Days Payable or its related term are showing as below:
OSTO:SEDANA'
s Days Payable Range Over the Past 10 Years
Min: 35.61 Med: 101.9 Max: 188.57
Current: 39.98
During the past 11 years, Sedana Medical AB's highest Days Payable was 188.57. The lowest was 35.61. And the median was 101.90.
OSTO:SEDANA's Days Payable is ranked worse than 75.85% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs OSTO:SEDANA: 39.98
Sedana Medical AB's Days Payable
increased
from Jun. 2025 (31.44) to Jun. 2026 (49.25).
It may suggest that Sedana Medical ABdelayed paying its suppliers.
The historical data trend for Sedana Medical AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SEDANA vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Sedana Medical AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sedana Medical AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Sedana Medical AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sedana Medical AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sedana Medical AB (OSTO:SEDANA) has a Days Payable of 49.25 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sedana Medical AB and its competitors. This is 52% below median its historical median of 101.90. Over the past decade, Sedana Medical AB's Days Payable has ranged from 35.61 to 188.57. According to the industry distribution chart, Sedana Medical AB ranks #603 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 75.8%.
Is Sedana Medical AB's Days Payable too high?
Sedana Medical AB's current Days Payable of 49.25 is 52% below median its 10-year median of 101.90. Over the past 10 years, this metric has ranged from a low of 35.61 to a high of 188.57. The Medical Devices & Instruments industry median Days Payable is 67.87. Sedana Medical AB's value of 49.25 is 27.4% below this industry median. Based on the distribution chart, Sedana Medical AB ranks #603 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sedana Medical AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sedana Medical AB ranks #603 out of 795 companies for Days Payable. This places Sedana Medical AB in the lower half of its industry. The industry median Days Payable is 67.87. Sedana Medical AB's value of 49.25 is 27.4% below this benchmark. Historically, Sedana Medical AB's own Days Payable has ranged from 35.61 to 188.57 over the past decade. While the company's 10-year median is 101.90 vs. the industry median of 67.87, Sedana Medical AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sedana Medical AB's current Days Payable of 49.25 is 27.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sedana Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sedana Medical AB's current Days Payable is 49.25, which is 52% below median its own 10-year median of 101.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Sedana Medical AB (OSTO:SEDANA) is currently considered Significantly Undervalued. The stock's GF Value™ is kr17.42, compared to a current price of kr9.80 — trading 43.7% below its estimated fair value. The current Days Payable is 49.25, which is 52% below median its 10-year median of 101.90 and 27.4% below the Medical Devices & Instruments industry median of 67.87. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sedana Medical AB (OSTO:SEDANA), the current Days Payable is 49.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sedana Medical AB (OSTO:SEDANA) Overvalued in 2026?
Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued.
The current stock price of kr9.80 is trading 43.7% below its estimated GF Value™ of kr17.42.
GuruFocus considers Sedana Medical AB to be Significantly Undervalued.
Key valuation signals for OSTO:SEDANA:
Days Payable: 49.25 (52% below median its 10-year median of 101.90)
GF Value™: kr17.42 vs. price of kr9.80 (43.7% below fair value)
Industry Position: 27.4% below the Medical Devices & Instruments median (#603 of 795)
No single metric tells the full story. See the OSTO:SEDANA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score
Get the complete analysis for OSTO:SEDANA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SEDANA has been successfully added to your 
